| Min Pa: | Min Pa(max): | Activity's type: |
| Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |
|---|---|---|---|---|---|---|
| 0.994 | 0.001 | 0.994 | T cell inhibitor | 0.993 0.001 DBMET00793 0.381 0.004 DBMET00826 0.894 0.001 DBMET00827 0.993 0.001 DBMET00443 | ||
| 0.959 | 0.004 | 0.959 | Apoptosis agonist | 0.958 0.004 DBMET00793 0.573 0.055 DBMET00826 0.881 0.008 DBMET00827 0.958 0.004 DBMET00443 | ||
| 0.928 | 0.004 | 0.928 | Angiogenesis inhibitor | 0.92 0.004 DBMET00793 0.661 0.011 DBMET00827 0.92 0.004 DBMET00443 | ||
| 0.924 | 0.001 | 0.924 | Falcipain inhibitor | 0.919 0.001 DBMET00793 0.736 0.001 DBMET00827 0.919 0.001 DBMET00443 | ||
| 0.924 | 0.001 | 0.924 | Falcipain 2 inhibitor | 0.918 0.001 DBMET00793 0.734 0.001 DBMET00827 0.918 0.001 DBMET00443 | ||
| 0.88 | 0.003 | 0.88 | Angiogenesis stimulant | 0.861 0.003 DBMET00793 0.765 0.004 DBMET00827 0.861 0.003 DBMET00443 | ||
| 0.87 | 0.003 | 0.87 | DNA damaging | 0.795 0.004 DBMET00793 0.465 0.018 DBMET00827 0.795 0.004 DBMET00443 | ||
| 0.766 | 0.004 | 0.78 | Immunosuppressant | 0.78 0.004 DBMET00793 0.645 0.008 DBMET00826 0.707 0.005 DBMET00827 0.78 0.004 DBMET00443 | DBMET00443 | |
| 0.682 | 0.003 | 0.682 | Interleukin 6 antagonist | 0.68 0.003 DBMET00793 0.242 0.025 DBMET00826 0.599 0.004 DBMET00827 0.68 0.003 DBMET00443 | ||
| 0.661 | 0.005 | 0.687 | Hypolipemic | 0.687 0.005 DBMET00793 0.171 0.117 DBMET00826 0.532 0.01 DBMET00827 0.687 0.005 DBMET00443 | DBMET00443 | |
| 0.633 | 0.015 | 0.661 | Antibacterial | 0.657 0.012 DBMET00793 0.661 0.012 DBMET00826 0.64 0.014 DBMET00827 0.657 0.012 DBMET00443 | DBMET00826 | |
| 0.605 | 0.002 | 0.621 | Interferon gamma antagonist | 0.621 0.002 DBMET00793 0.166 0.06 DBMET00826 0.519 0.005 DBMET00827 0.621 0.002 DBMET00443 | DBMET00443 | |
| 0.585 | 0.003 | 0.585 | Antibacterial (Helicobacter pylori) | 0.482 0.004 DBMET00793 0.201 0.022 DBMET00827 0.482 0.004 DBMET00443 | ||
| 0.58 | 0.008 | 0.63 | DNA synthesis inhibitor | 0.63 0.006 DBMET00793 0.359 0.028 DBMET00826 0.458 0.017 DBMET00827 0.63 0.006 DBMET00443 | DBMET00443 | |
| 0.44 | 0.003 | 0.451 | Interleukin 12 antagonist | 0.451 0.003 DBMET00793 0.231 0.005 DBMET00827 0.451 0.003 DBMET00443 | DBMET00443 | |
| 0.488 | 0.065 | 0.561 | Caspase 9 stimulant | 0.561 0.042 DBMET00793 0.389 0.118 DBMET00827 0.561 0.042 DBMET00443 | DBMET00443 | |
| 0.43 | 0.057 | 0.477 | Transcription factor NF kappa B inhibitor | 0.477 0.048 DBMET00793 0.242 0.133 DBMET00826 0.438 0.055 DBMET00827 0.477 0.048 DBMET00443 | DBMET00443 | |
| 0.373 | 0.029 | 0.538 | Nitric oxide antagonist | 0.448 0.02 DBMET00793 0.458 0.019 DBMET00826 0.538 0.013 DBMET00827 0.448 0.02 DBMET00443 | DBMET00827 | |
| 0.384 | 0.043 | 0.384 | Apoptosis antagonist | 0.371 0.047 DBMET00793 0.267 0.111 DBMET00826 0.305 0.082 DBMET00827 0.371 0.047 DBMET00443 | ||
| 0.255 | 0.012 | 0.255 | Interleukin 1b antagonist | 0.147 0.043 DBMET00793 0.147 0.043 DBMET00443 | ||
| 0.188 | 0.006 | 0.188 | Glutathione S-transferase inhibitor | 0.172 0.008 DBMET00793 0.08 0.061 DBMET00827 0.172 0.008 DBMET00443 | ||
| 0.115 | 0.011 | 0.257 | Bcl2 antagonist | 0.105 0.015 DBMET00793 0.257 0.003 DBMET00827 0.105 0.015 DBMET00443 | DBMET00827 | |
| 0.197 | 0.112 | 0.256 | Tumour necrosis factor alpha release inhibitor | 0.256 0.072 DBMET00793 0.256 0.072 DBMET00443 | DBMET00443 | |
| 0.154 | 0.084 | 0.204 | Arachidonic acid antagonist | 0.183 0.05 DBMET00793 0.204 0.029 DBMET00826 0.2 0.033 DBMET00827 0.183 0.05 DBMET00443 | DBMET00826 | |
| 0.139 | 0.077 | 0.171 | Ca2+-transporting ATPase inhibitor | 0.161 0.022 DBMET00793 0.152 0.038 DBMET00826 0.171 0.012 DBMET00827 0.161 0.022 DBMET00443 | DBMET00827 | |
| 0.132 | 0.074 | 0.132 | Interleukin 1 antagonist | 0.12 0.088 DBMET00826 | ||
| 0.094 | 0.038 | 0.115 | Na+ K+ transporting ATPase inhibitor | 0.107 0.026 DBMET00793 0.088 0.042 DBMET00826 0.115 0.02 DBMET00827 0.107 0.026 DBMET00443 | DBMET00827 | |
| 0.1 | 0.046 | 0.58 | Antineoplastic antibiotic | 0.098 0.047 DBMET00793 0.58 0.003 DBMET00826 0.105 0.044 DBMET00827 0.098 0.047 DBMET00443 | DBMET00826 | |
| 0.209 | 0.156 | 0.236 | Caspase 3 stimulant | 0.236 0.126 DBMET00793 0.236 0.126 DBMET00443 | DBMET00443 | |
| 0.106 | 0.06 | 0.106 | Toll-Like receptor 4 antagonist | |||
| 0.061 | 0.03 | 0.146 | Protein 50S ribosomal subunit inhibitor | 0.063 0.029 DBMET00793 0.146 0.007 DBMET00826 0.07 0.024 DBMET00827 0.063 0.029 DBMET00443 | DBMET00826 | |
| 0.062 | 0.032 | 0.075 | Lipocortins synthesis agonist | 0.071 0.02 DBMET00793 0.072 0.02 DBMET00826 0.075 0.017 DBMET00827 0.071 0.02 DBMET00443 | DBMET00827 | |
| 0.049 | 0.024 | 0.512 | Smo receptor antagonist | 0.512 0.004 DBMET00827 | DBMET00827 | |
| 0.067 | 0.06 | 0.196 | Glycine receptor agonist | 0.078 0.041 DBMET00793 0.196 0.004 DBMET00826 0.097 0.023 DBMET00827 0.078 0.041 DBMET00443 | DBMET00826 | |
| 0.232 | 0.233 | 0.287 | Cyclophilin D inhibitor | 0.287 0.174 DBMET00793 0.281 0.18 DBMET00827 0.287 0.174 DBMET00443 | DBMET00443 | |
| 0.03 | 0.038 | 0.035 | Antibiotic Aminoglycoside-like | 0.035 0.028 DBMET00827 | DBMET00827 | |
| 0.02 | 0.03 | 0.027 | RNA-directed RNA polymerase stimulant | 0.025 0.024 DBMET00826 0.027 0.023 DBMET00827 | DBMET00827 | |
| 0.015 | 0.03 | 0.02 | Corticosteroid-like | 0.019 0.018 DBMET00826 0.02 0.017 DBMET00827 | DBMET00827 | |
| 0.005 | 0.021 | 0.018 | Antibiotic Macrolide-like | 0.018 0.007 DBMET00826 | DBMET00826 | |
| 0.076 | 0.108 | 0.164 | Anabolic | 0.104 0.057 DBMET00793 0.164 0.012 DBMET00826 0.12 0.039 DBMET00827 0.104 0.057 DBMET00443 | DBMET00826 | |
| 0.119 | 0.153 | 0.475 | Hepatoprotectant | 0.153 0.106 DBMET00793 0.475 0.008 DBMET00826 0.182 0.078 DBMET00827 0.153 0.106 DBMET00443 | DBMET00826 | |
| 0.02 | 0.057 | 0.025 | Toll-Like receptor 4 agonist | 0.025 0.022 DBMET00827 | DBMET00827 | |
| 0.126 | 0.179 | 0.202 | Neurotrophic factor enhancer | 0.198 0.079 DBMET00793 0.16 0.123 DBMET00826 0.202 0.075 DBMET00827 0.198 0.079 DBMET00443 | DBMET00827 | |
| 0.055 | 0.113 | 0.142 | Glycine receptor antagonist | 0.092 0.04 DBMET00793 0.142 0.009 DBMET00826 0.114 0.022 DBMET00827 0.092 0.04 DBMET00443 | DBMET00826 | |
| 0.064 | 0.123 | 0.123 | Transcription factor NF kappa B stimulant | 0.11 0.031 DBMET00793 0.094 0.046 DBMET00826 0.123 0.024 DBMET00827 0.11 0.031 DBMET00443 | DBMET00827 | |
| 0.015 | 0.076 | 0.081 | 5-Alpha-reductase inhibitor | 0.081 0.012 DBMET00826 0.042 0.023 DBMET00827 | DBMET00826 | |
| 0.091 | 0.16 | 0.158 | Diuretic | 0.158 0.071 DBMET00793 0.158 0.071 DBMET00443 | DBMET00443 | |
| 0.134 | 0.209 | 0.328 | Hypoglycemic | 0.328 0.044 DBMET00793 0.278 0.061 DBMET00827 0.328 0.044 DBMET00443 | DBMET00443 | |
| 0.109 | 0.197 | 0.151 | Lipocortins synthesis antagonist | 0.151 0.103 DBMET00827 | DBMET00827 | |
| 0.026 | 0.147 | 0.048 | Glucose-6-phosphate isomerase inhibitor | 0.044 0.04 DBMET00826 0.048 0.032 DBMET00827 | DBMET00827 | |
| 0.054 | 0.177 | 0.116 | Cholesterol synthesis inhibitor | 0.116 0.069 DBMET00826 | DBMET00826 | |
| 0.05 | 0.174 | 0.158 | ATPase (Vacuolar H+) inhibitor | 0.158 0.006 DBMET00826 | DBMET00826 | |
| 0.022 | 0.15 | 0.064 | Microtubule stabilization | 0.064 0.011 DBMET00826 | DBMET00826 | |
| 0.061 | 0.19 | 0.134 | Microtubule formation inhibitor | 0.134 0.047 DBMET00826 | DBMET00826 | |
| 0.119 | 0.283 | 0.293 | Cholesterol antagonist | 0.219 0.149 DBMET00793 0.225 0.144 DBMET00826 0.293 0.095 DBMET00827 0.219 0.149 DBMET00443 | DBMET00827 | |
| 0.077 | 0.252 | 0.434 | Interleukin antagonist | 0.434 0.026 DBMET00826 | DBMET00826 | |
| 0.116 | 0.305 | 0.204 | RNA-directed DNA polymerase inhibitor | 0.168 0.156 DBMET00793 0.204 0.094 DBMET00827 0.168 0.156 DBMET00443 | DBMET00827 | |
| 0.13 | 0.358 | 0.218 | Interleukin 2 agonist | 0.218 0.16 DBMET00827 | DBMET00827 | |
| 0.038 | 0.321 | 0.12 | Alpha-N-acetylglucosaminidase inhibitor | 0.12 0.078 DBMET00827 | DBMET00827 | |
| 0.006 | 0.354 | 0.03 | Caspase 2 inhibitor | 0.03 0.024 DBMET00827 | DBMET00827 | |
| 0.092 | 0.491 | 0.188 | Peptidyltransferase inhibitor | 0.188 0.116 DBMET00826 | DBMET00826 | |
| 0.004 | 0.448 | 0.033 | HMG CoA reductase inhibitor | 0.033 0.027 DBMET00826 | DBMET00826 | |
| 0.004 | 0.459 | 0.078 | Estrogen agonist | 0.078 0.023 DBMET00826 | DBMET00826 | |
| 0.028 | 0.487 | 0.076 | Thioredoxin reductase inhibitor | 0.076 0.073 DBMET00826 | DBMET00826 | |
| 0.03 | 0.537 | 0.343 | Antioxidant | 0.343 0.048 DBMET00826 | DBMET00826 | |
| 0.011 | 0.615 | 0.22 | Neurotrophic factor | 0.137 0.072 DBMET00826 0.22 0.02 DBMET00827 | DBMET00827 | |
| 0.011 | 0.652 | 0.324 | Protease inhibitor | 0.324 0.005 DBMET00826 | DBMET00826 | |
| 0.004 | 0.681 | 0.039 | HIV-1 protease inhibitor | 0.039 0.037 DBMET00826 | DBMET00826 | |
| 0.006 | 0.756 | 0.078 | CDC25A inhibitor | 0.078 0.046 DBMET00826 | DBMET00826 | |
| 0.008 | 0.781 | 0.277 | Free radical scavenger | 0.277 0.058 DBMET00826 | DBMET00826 | |
| 0.011 | 0.859 | 0.467 | Platelet adhesion inhibitor | 0.467 0.007 DBMET00826 | DBMET00826 | |
| 0.003 | 0.972 | 0.03 | Caspase 6 inhibitor | 0.03 0.022 DBMET00827 | DBMET00827 | |
| 0.008 | 0.986 | 0.888 | Interleukin 4 antagonist | 0.888 0.002 DBMET00826 | DBMET00826 | |
| 0.005 | 0.984 | 0.708 | Antiinflammatory | 0.708 0.029 DBMET00826 | DBMET00826 | |
| 0.004 | 0.984 | 0.111 | Estrogen antagonist | 0.111 0.073 DBMET00826 | DBMET00826 | |
| 0.004 | 0.99 | 0.169 | Platelet antagonist | 0.169 0.126 DBMET00826 | DBMET00826 | Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |